Canadian scientists have conducted a new study on a specific type of diabetes medication and have identified the possibility of using it to treat cancer patients.
The magazine “PLOS ONE” published the results of Canadian specialists on Metformin, used in the treatment of type 2 diabetes, in which they demonstrated the possibility of preventing the random division of cancer cells.
The researchers tested the effect of the drug on a group of laboratory mice in which human cancer cells were planted , and found that giving mice this drug slowed or prevented the growth of cancer cells that were not treated with the drug “Doxorubicin” (a drug that stops the growth of cells Tumors by interfering with DNA).
The scientists believe that “Metformin”, can help to affect the cancer cells of the mammary gland and make them susceptible to interaction with chemotherapy for this type of malignant tumor disease. Scientists are also planning to continue this research until it reaches human clinical trials that will most likely lead to the use of drugs to treat cancer.
French scientists have demonstrated the possibility of using the drug, “Nolomb”, which treats cancer, in the treatment of AIDS patients.